Thor Haahr

ORCID: 0000-0001-9304-5299 · 6 papers in corpus
rct 2025
Nature communications ·doi:10.1038/s41467-025-60205-6

The primary aim of the present randomised, double-blind, placebo-controlled trial was to investigate whether clindamycin and live Lactobacillus crispatus CTV-05 (LACTIN-V) would improve clinical pregnancy rates in IVF patients with abnormal…

observational 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03629-9

PURPOSE: To investigate baseline parameters and vaginal intimate hygiene habits comparing IVF patients with and without vaginal dysbiosis, a cross-sectional study. METHODS: Patients were grouped by the presence of vaginal dysbiosis status …

review 2021
Pathogens (Basel, Switzerland) ·doi:10.3390/pathogens10030295

Recent advances in molecular microbiology have enabled refined studies of the genital tract microbiota. This constitutes the basis of the present updated systematic review and meta-analysis which investigate vaginal dysbiosis (VD) as define…

other 2020
BMJ open ·doi:10.1136/bmjopen-2019-035866

INTRODUCTION: Recent studies in in vitro fertilisation (IVF) patients have associated abnormal vaginal microbiota (AVM) with poor clinical pregnancy rates of 6%-9% per embryo transfer. The biological plausibility for this finding is hypothe…

other 2020
Annals of clinical microbiology and antimicrobials ·doi:10.1186/s12941-020-00385-9
review 2019
Panminerva medica ·doi:10.23736/S0031-0808.18.03492-4

Over the years concerns have arisen about possible adverse effects associated with controlled ovarian stimulation (COS) as regards not only the endometrium, but also on obstetrical and perinatal outcomes in pregnancies after fresh embryo tr…